| Views of practitioners and researchers on the use of virtual reality in treatments for substance use disorders R Skeva, L Gregg, C Jay, S Pettifer Frontiers in Psychology 12, 606761, 2021 | 20 | 2021 |
| Exploring the current practices, costs and benefits of FAIR implementation in pharmaceutical research and development: a qualitative interview study E Alharbi, R Skeva, N Juty, C Jay, C Goble Data Intelligence 3 (4), 507-527, 2021 | 16 | 2021 |
| Public perceptions and interactions with UK COVID-19 Test, Trace and Isolate policies, and implications for pandemic infectious disease modelling GC Marshall, R Skeva, C Jay, MEP Silva, M Fyles, T House, EL Davis, ... MedRxiv, 2022.01. 31.22269871, 2022 | 8 | 2022 |
| A FAIR-Decide framework for pharmaceutical R&D: FAIR data cost–benefit assessment E Alharbi, R Skeva, N Juty, C Jay, C Goble Drug discovery today 28 (4), 103510, 2023 | 6 | 2023 |
| How are websites used during development and what are the implications for the coding process? O Alghamdi, S Clinch, R Skeva, C Jay Journal of Systems and Software 205, 111803, 2023 | 5 | 2023 |
| Assessment of virtual environments for alcohol Relapse Prevention in a less immersive and cost-effective setup: A qualitative study R Skeva, L Gregg, C Jay, S Pettifer Computers in Human Behavior Reports 4, 100120, 2021 | 3 | 2021 |
| Tracking the structure and sentiment of vaccination discussions on Mumsnet MEP Silva, R Skeva, T House, C Jay Social Network Analysis and Mining 13 (1), 152, 2023 | 1 | 2023 |
| Alcohol Treatment Preferences and the Acceptability of Virtual Reality Therapy for Treating Alcohol Misuse in Adult Drinkers R Skeva, C Jay, S Pettifer, L Gregg Alcohol, 2024 | | 2024 |
| Virtual Reality Therapy for Alcohol Relapse Prevention R Skeva PQDT-Global, 2022 | | 2022 |
